CoChat

Endothelial glycocalyx-associated molecules as potential serological markers for sepsis-associated encephalopathy: A systematic review and meta-analysis

Open access

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

Background: Sepsis-associated encephalopathy (SAE) is characterized by a diffuse cerebral dysfunction that accompanies sepsis in the absence of direct central nervous system infection. The endothelial glycocalyx is a dynamic mesh containing heparan sulfate linked to proteoglycans and glycoproteins, including selectins and vascular/intercellular adhesion molecules (V/I-CAMs), which protects the endothelium while mediating mechano-signal transduction between the blood and vascular wall. During severe inflammatory states, components of the glycocalyx are shed into the circulation and can be detected in soluble forms. Currently, SAE remains a diagnosis of exclusion and limited information is available on the utility of glycocalyx-associated molecules as biomarkers for SAE. We set out to synthesize all available evidence on the association between circulating molecules released from the endothelial glycocalyx surface during sepsis and sepsis-associated encephalopathy. Methods: MEDLINE (PubMed) and EMBASE were searched since inception until May 2, 2022 to identify eligible studies. Any comparative observational study: i) evaluating the association between sepsis and cognitive decline and ii) providing information on level of circulating glycocalyx-associated molecules was eligible for inclusion. Results: Four case-control studies with 160 patients met the inclusion criteria. Meta-analysis of biomarkers ICAM-1 (SMD 0.41; 95% CI 0.05–0.76; p = 0.03; I 2= 50%) and VCAM-1 (SMD 0.55; 95% CI 0.12–0.98; p = 0.01; I 2= 82%) revealed higher pooled mean concentration in patients with SAE compared to the patients with sepsis alone. Single studies reported elevated levels of P-selectin (MD 0.80; 95% CI -17.77–19.37), E-selectin (MD 96.40; 95% Cl 37.90–154.90), heparan sulfate NS2S (MD 19.41; 95% CI 13.37–25.46), and heparan sulfate NS+NS2S+NS6S (MD 67.00; 95% CI 31.00–103.00) in patients with SAE compared to the patients with sepsis alone. Conclusion: Plasma glycocalyx-associated molecules are elevated in SAE and may be useful for early identification of cognitive decline in sepsis patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0281941

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 The PRISMA flow diagram. Our initial search yielded 862 citations, of which 29 duplicated were excluded. The abstracts of the remaining 833 citations were carefully checked and 829 were excluded. Ultimately, 4 studies were included in this analysis.
Fig 1 The PRISMA flow diagram. Our initial search yielded 862 citations, of which 29 duplicated were excluded. The abstracts of the remaining 833 citations were carefully checked and 829 were excluded. Ultimately, 4 studies were included in this analysis.CC BY · PubMed Central
Fig 2 Levels of ICAM-1 and VCAM-1. Three studies (140 patients) reported data for ICAM-1 (A), and two studies (100 patients) reported data for VCAM-1 (B). The pooled mean concentration of ICAM-1 was higher in patients with SAE compared to the patients with sepsis alone (SMD 0.41; 95% CI 0.05–0.76; p = 0.03), and there was moderate heterogeneity (I2 = 50%) between studies. The pooled mean concentration of VCAM-1 was higher in patients with SAE compared to the patients with sepsis alone (SMD 0.55; 95% CI 0.12–0.98; p = 0.01), and the heterogeneity between studies was high (I2 = 82%).
Fig 2 Levels of ICAM-1 and VCAM-1. Three studies (140 patients) reported data for ICAM-1 (A), and two studies (100 patients) reported data for VCAM-1 (B). The pooled mean concentration of ICAM-1 was higher in patients with SAE compared to the patients with sepsis alone (SMD 0.41; 95% CI 0.05–0.76; p = 0.03), and there was moderate heterogeneity (I2 = 50%) between studies. The pooled mean concentration of VCAM-1 was higher in patients with SAE compared to the patients with sepsis alone (SMD 0.55; 95% CI 0.12–0.98; p = 0.01), and the heterogeneity between studies was high (I2 = 82%).CC BY · PubMed Central
Fig 3 Levels of other biomarkers reported only by single studies. Single studies reported higher mean concentrations of P-selectin, E-selectin, and heparan sulfates in patients with SAE compared to patients with sepsis alone.
Fig 3 Levels of other biomarkers reported only by single studies. Single studies reported higher mean concentrations of P-selectin, E-selectin, and heparan sulfates in patients with SAE compared to patients with sepsis alone.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Research works printed but not linked: 2

  1. JD Esko, 2009, Essentials of Glycobiology.
  2. PV Zenaide, 2013, Biomarkers in septic encephalopathy: a systematic review of clinical studies., Rev Bras Ter Intensiva, 25, 56

Cited by

See all 18

Metadata

Authors
Baby, S., Reljic, T., Villalba, N., Kumar, A., & Yuan, S. Y.
Affiliations
University of South Florida (US)
Corresponding author
Yuan, Sarah Y.
Venue
PLOS ONE
Published
2023-02-21
Volume
18
Issue
2
Pages
e0281941
ISSN
1932-6203 (ISSN-L)
OpenAlex
W4321441045
Cited by
17
References
68
Citations by year
2026: 4 · 2025: 5 · 2024: 5 · 2023: 3
FWCI
0.66
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • University of South Florida (Research, Innovation & Scholarly Endeavors)
  • National Institutes of Health (HL150732, GM097270, GM142110)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
sepsis-associated encephalopathy, endothelial glycocalyx, biomarkers, ICAM-1, VCAM-1, P-selectin, E-selectin, heparan sulfate, soluble adhesion molecules, cognitive decline, sepsis, endothelial dysfunction, neuroinflammation, neuroprotection, sepsis mortality, sepsis severity, prognostic factors
MeSH terms
Heparan Sulfate, Humans, Biomarkers, Cell Adhesion Molecules, Sepsis, Glycocalyx, Observational Studies as Topic, Sepsis-Associated Encephalopathy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endothelial glycocalyx-associated molecules as potential serological markers for sepsis-associated encephalopathy: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1371/journal.pone.0281941
The paper
Baby, S., Reljic, T., Villalba, N., Kumar, A., & Yuan, S. Y. (2023). Endothelial glycocalyx-associated molecules as potential serological markers for sepsis-associated encephalopathy: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0281941

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.